Cyclophosphamide Injection
Product Images NDC 0338-9779

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 0338-9779). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclophosphamide Structural Formula.jpg (Image 01)

Chemical structure of cyclophosphamide as shown in the image, including the phosphoramide mustard moiety and associated chemical groups, with a water molecule (H2O) indicated.*

FDA Label Image

Container Label Ndc 0338-9777-01.jpg (Image 02)

Label for Cyclophosphamide Injection 200 mg/2.5 mL (200 mg/mL) intravenous use by Baxter Healthcare Company. The label indicates it is a multiple-dose vial, requiring refrigeration at 2° to 8°C (36° to 46°F). The product contains 214 mg cyclophosphamide monohydrate equivalent to 200 mg cyclophosphamide USP.*

FDA Label Image

Carton Label Ndc 0338-9777-01.jpg (Image 03)

Label for Cyclophosphamide Injection 500 mg/2.5 mL (200 mg/mL) sterile, nonpyrogenic, preservative-free solution for intravenous use. The product requires dilution before intravenous use, is labeled as a hazardous drug, and comes in a multiple-dose vial. Manufactured for Baxter Healthcare Corporation, Deerfield, IL, USA.*

FDA Label Image

Container Label Ndc 0338-9779-01.jpg (Image 04)

Cyclophosphamide injection, 200 mg/mL in a 1,000 mg/5 mL vial, by Baxter Healthcare Company. Label indicates it is a prescription intravenous injection, multiple-dose vial. Storage instructions specify refrigeration at 2° to 8°C (36° to 46°F). The label warns that it is a hazardous drug and must be used before a specified date.*

FDA Label Image

Carton Label Ndc 0338-9779-01.jpg (Image 05)

Cyclophosphamide Injection 1,000 mg/5 mL (200 mg/mL) vial label for intravenous use. The multi-panel label highlights dilution instructions, sterile nonpyrogenic preservative-free solution, hazardous drug warning, storage conditions, and manufacturer Baxter Healthcare Corporation, Deerfield, IL. Barcode and NDC 0338-9779-01 are present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.